| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $576.4M | -6.5% |
| Cost of Revenue | $135.4M | +5.8% |
| Gross Profit | $441.1M | -9.8% |
| R&D Expense | $130.5M | +11.5% |
| SG&A Expense | $67.4M | -13.5% |
| Operating Income | $217.2M | -18.7% |
| Pre-tax Income | $245.2M | -8.6% |
| Income Tax | $42.2M | -27.5% |
| Net Income | $203.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.0M | -1.5% |
| Short-term Investments | $422.1M | -12.8% |
| Accounts Receivable | $139.8M | +50.9% |
| Inventory | $175.8M | -4.1% |
| Current Assets | $917.1M | +2.0% |
| Total Assets | $1.67B | +8.9% |
| Current Liabilities | $118.8M | -12.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $154.8M | +22.0% |
| Capital Expenditures | $59.8M | +40.7% |
| Investing Cash Flow | -$83.3M | +70.3% |
| Financing Cash Flow | -$72.9M | -12.8% |
| Free Cash Flow | $95.0M | +12.7% |
| -3.4% |
| EPS (Basic) | $4.25 | -3.6% |
| EPS (Diluted) | $4.24 | -3.6% |
| Total Liabilities |
| $221.7M |
| -13.9% |
| Stockholders' Equity | $1.45B | +13.5% |